Improved fluorescence assays to measure the defects associated with F508del-CFTR allow identification of new active compounds. (2017)
Attributed to:
A Translational Research Resource Centre and Image-Based Screening Platform for MRC-LMCB, UCL.
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1111/bph.13715
PubMed Identifier: 28094839
Publication URI: http://europepmc.org/abstract/MED/28094839
Type: Journal Article/Review
Volume: 174
Parent Publication: British journal of pharmacology
Issue: 7
ISSN: 0007-1188